FDA employee credit card use to be audited by HHS Inspector General -- FY 1997 work plan.
FDA CREDIT CARD USE TO BE AUDITED BY HHS INSPECTOR GENERAL this fiscal year, the HHS IG says in an FY 1997 work plan. The office says it plans to "review FDA's management controls related to credit cards used for small purchases under $2,500."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth